| 摘要 |
A compound represented by formula (I), or a pharmaceutically acceptable salt thereof, acts as an FGFR inhibitor. [In the formula: A represents a C6-10 arylene group or the like that may have a substituent; J represents a C3-10 nitrogen-containing non-aromatic heterocyclic group or the like that may have 1-3 substituents selected from the L group of substituents; R1, R2, and R3 represent a hydrogen atom or the like; R4 represents a C1-6 alkyl group that may have a substituent; R5 represents a hydroxy C1-6 alkyl group that may be substituted with 1-3 halogen atoms; R6, R7, R8, R9, and R10 each independently represents a hydrogen atom or the like; and the L group of substituents represents a group that comprises C1-6 alkyl groups or the like that may be substituted with 1 or 2 hydroxyl groups.] |
